Compounding Pharmacies Should Expect Greater Scrutiny as Government Healthcare Budgets Get Squeezed
August 10, 2017

Government Contracts Navigator

As Congress continues to grapple over healthcare reform, there are many uncertainties. However, one thing is clear: as government healthcare funding shrinks, federal and state enforcement agencies will continue to target compounding pharmacies for potential fraud.

Compounded drug use and related government spending, particularly on topical creams and ointments, has skyrocketed. Many argue that drug compounding regulation remains murky, making it too easy to prosecute traditional compounders. Compounding advocates suggest regulation of compounders has been heavy-handed and ignores the multiple benefits associated with compounding. Arguably, these competing tensions have led to ineffective industry regulation.

To read the full blog post, please click here.

Government Contracts
Healthcare Regulatory Compliance
Merle M. DeLancey, Jr.